Lindis biotech presents encouraging data from bladder cancer trial
Data revealed that 100% of patients achieved a complete remission with no recurrence
Read More
Tag: bladder
NICE recommends wireless device for overactive bladder
The device has potential to save the NHS around £6,200 per patient assuming a 15-year life span.
Read More
Merck’s Bavencio hits targets in bladder cancer interim analysis
Last year the drug disappointed in the Phase III JAVELIN Gastric 100 study, but has pulled itself back with new urothelial carcinoma data.
Read More
Tecentriq combo proves effective in bladder cancer
The drug improved progression-free survival to 8.2 months from 6.3 months.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
